SOCS3

細胞因子信號傳導抑制因子3(SOCS3或 SOCS-3)是一種在人體內由 SOCS3基因編碼的蛋白。 該基因編碼 STAT- 誘導的 STAT 抑制子(SSI)，也可稱為細胞因子信號轉導(SOCS)家族抑制子，的一個成員。 SSI 家族成員是可由細胞因子誘導的細胞因子信號轉導負調節因子。

**功能**
SOCS3基因的表達可由多種細胞因子的誘導，包括 IL-6，IL-10，干擾素-γ(IFN-γ)。
在 IL-6，Epo，GCSF 和瘦素的信號傳導中，已發現SOCS3在各自的細胞因子受體上的結合對 SOCS3的抑制功能而言是至關重要的。
SOCS3的過表達會抑制脂肪組織和肝臟胰島素信號轉導，但對肌肉則不然。 但是在小鼠骨骼肌中敲除 SOCS3可以保護小鼠免於肥胖相關的胰島素抵抗。
由於神經酰胺合成的增加，SOCS3會增加瘦素抵抗和胰島素抵抗。 因此，研究已表明去除 SOCS 基因可以預防肥胖症患者的胰島素抵抗
對該小鼠中基因的同源基因的研究表明，該基因在胎兒肝臟造血和胎盤發育的負調控中發揮作用。
SOCS3蛋白能與JAK2結合，抑制其活性。

**相互作用**
已經證明 SOCS3可以與下列物質相互作用:- 促紅細胞生成素受體- 糖蛋白130- 胰島素樣生長因子1受體- JAK2- PTPN11- RAS p21蛋白激活因子1

**調控**
有部分證據表明 SOCS3的表達受小分子核糖核酸 miR-203的調控。

**參見**
 SOCS- JAK-STAT信號通路

**參考文獻**

**擴展閱讀**
 Yasukawa H, Sasaki A, Yoshimura A (2000). "Negative regulation of cytokine signaling pathways". Annu. Rev. Immunol. 18: 143–64. doi:10.1146/annurev.immunol.18.1.143. PMID  10837055date=20181123065522 .- Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM, Hilton DJ (2002). "The SOCS box: a tale of destruction and degradation". Trends Biochem. Sci. 27 (5): 235–41. doi:10.1016/S0968-0004(02)02085-6. PMID  1276535date=20181123022802 .- Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SB, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M (1999).  "The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation". Proc. Natl. Acad. Sci. U.S.A. 96 (5): 2071–6. doi:10.1073/pnas.96.5.2071. PMC  26738. PMID  10051596date=20181123022925 .- Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A (1999). "Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain". Genes Cells. 4 (6): 339–51. doi:10.1046/j.1365-2443.1999.00263.x. PMID  10421843date=20181123065541 .- Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa H, Sasaki A, Yoshimura A, Ihle JN (1999). "SOCS3 is essential in the regulation of fetal liver erythropoiesis". Cell. 98 (5): 617–27. doi:10.1016/S0092-8674(00)80049-5. PMID  10490101date=20181123022820 .- Schmitz J, Weissenbach M, Haan S, Heinrich PC, Schaper F (2000). "SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130". J. Biol. Chem. 275 (17): 12848–56. doi:10.1074/jbc.275.17.12848. PMID  10777583date=20181123065610 .- Ram PA, Waxman DJ (2000). "SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms". J. Biol. Chem. 274 (50): 35553–61. doi:10.1074/jbc.274.50.35553. PMID  10585430date=20181123023005 .- Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A (2000). "CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2". J. Biol. Chem. 275 (38): 29338–47. doi:10.1074/jbc.M003456200. PMID  10882725date=20181123065552 .- Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F (2000). "Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation". J. Immunol. 165 (5): 2535–43. doi:10.4049/jimmunol.165.5.2535. PMID  10946280date=20181123022958 . - Bjorbak C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS, Myers MG (2001). "SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985". J. Biol. Chem. 275 (51): 40649–57. doi:10.1074/jbc.M007577200. PMID  11018044date=20181123022739 . - Shen X, Hong F, Nguyen VA, Gao B (2000). "IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3". FEBS Lett. 480 (2–3): 132–6. doi:10.1016/S0014-5793(00)01905-0. PMID  11034314date=20181123022927 . - Dey BR, Furlanetto RW, Nissley P (2001). "Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor". Biochem. Biophys. Res. Commun. 278 (1): 38–43. doi:10.1006/bbrc.2000.3762. PMID  11071852date=20181123023110 . - Hartley JL, Temple GF, Brasch MA (2001).  "DNA cloning using in vitro site-specific recombination" date=20220424204317 . Genome Res. 10 (11): 1788–95. doi:10.1101/gr.143000. PMC  310948 date=20220424204317 . PMID  11076863date=20181123022814 . - Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, Cox HE, Coleman R, Leaves NI, Trembath RC, Moffatt MF, Harper JI (2001). "Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci". Nat. Genet. 27 (4): 372–3. doi:10.1038/86867. PMID  11279517date=20181123065513 . - Cacalano NA, Sanden D, Johnston JA (2001). "Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras". Nat. Cell Biol. 3 (5): 460–5. doi:10.1038/35074525. PMID  11331873date=20181123022755 . - Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, Hilton DJ, Alexander WS (2001).  "Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3". Proc. Natl. Acad. Sci. U.S.A. 98 (16): 9324–9. doi:10.1073/pnas.161271798. PMC  55419. PMID  11481489date=20181123023026 . - Dif F, Saunier E, Demeneix B, Kelly PA, Edery M (2001). "Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor". Endocrinology. 142 (12): 5286–93. doi:10.1210/endo.142.12.8549. PMIDPMID  11713228date=20181123023130 . - Bode JG, Ludwig S, Freitas CA, Schaper F, Ruhl M, Melmed S, Heinrich PC, Häussinger D (2002). "The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription". Biol. Chem. 382 (10): 1447–53. doi:10.1515/BC.2001.178. PMID  11727828date=20181123022849 .